EGISTs have certain tissue immune markers, including C-kit (CD117), CD34, and DOG-1; however, these are not specific, obstructing the differentiation of retroperitoneal EGISTs from other retroperitoneal sarcomas (5, 6). This evidence concerns the gene KIT and retroperitoneal sarcoma.